Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vision 2024

Set Alert for Medtech Insight - Vision 2024

2024 Radar: UK Medtechs Up The Pace On Sustainability And Assess AI Potential

Three UK medtech companies’ views on how their businesses will be influenced by external factors in the coming year.

United Kingdom Medical Device

Priority Projects For 2024 To Aid IVDR Implementation

The latest insights into work conducted to support the implementation of the IVDR show that much has been achieved already. Ongoing projects remain, however, including those that are continuous. 2024 promises to be a busy year. 

Europe EU

ESG In 2024: Stakeholder Views From ‘Strategic Imperative’ To ‘Largely A Nonsense’

Medtech Insight and HBW Insight reached out to industry stakeholders for feedback on new climate-related disclosure requirements and growing environmental, social and governance (ESG) pressures on businesses.

Regulation Sustainability

'Blah-Blah' May Subside, But Harnessing AI Ethically, Impactfully Is Key For Medtech In 2024

Views from medtech industry leaders and investors on the most significant uncertainties and opportunities facing the sector in 2024. 

Artificial Intelligence Cybersecurity

FDA’s LDT Proposal, AI Oversight, Cybersecurity Top US Regulatory Interests In 2024

Views from industry experts and the US FDA on priorities and regulatory topics to watch in 2024. 

Regulation Legal Issues

Is EU Medtech Regulatory Reform On The Horizon? Seven Expert Perspectives Entering 2024

Ongoing threats to the availability of medical devices, obstacles to innovation, delayed structures and documents.... The medtech sector has plenty of reason to call for change in 2024.

Regulation Innovation

MTI 100 Outlook 2024: Shaping An Environment Where Technology Leads The Way

Compliance with greenhouse gas reduction targets is not optional for medtech businesses who, besides the bigger picture, have their own sustainability to think of. Environmental demands, the evolution of care models, new delivery technologies and AI tools are influencing how medtechs must approach innovation. In the EU, the MDR is also having an effect on innovation strategies.

Medtech 100 Policy
See All